17,819 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Trexquant Investment LP

Trexquant Investment LP bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,819 shares of the medical equipment provider’s stock, valued at approximately $9,301,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Atala Financial Inc bought a new position in Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Summit Securities Group LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $507.05 on Thursday. The company has a market cap of $180.60 billion, a price-to-earnings ratio of 79.10, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s 50 day simple moving average is $550.11 and its two-hundred day simple moving average is $532.84.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ISRG shares. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Finally, Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.